<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HA99455269F64407B91B4F7270407BD5F" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 2107 IH: Children’s Hospital GME Support Reauthorization Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-03-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2107</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250314">March 14, 2025</action-date><action-desc><sponsor name-id="C001120">Mr. Crenshaw</sponsor> (for himself, <cosponsor name-id="M001211">Mrs. Miller of Illinois</cosponsor>, <cosponsor name-id="M001215">Mrs. Miller-Meeks</cosponsor>, <cosponsor name-id="P000048">Mr. Pfluger</cosponsor>, <cosponsor name-id="E000071">Mr. Ellzey</cosponsor>, <cosponsor name-id="V000133">Mr. Van Drew</cosponsor>, <cosponsor name-id="G000590">Mr. Green of Tennessee</cosponsor>, <cosponsor name-id="R000603">Mr. Rouzer</cosponsor>, <cosponsor name-id="H001086">Mrs. Harshbarger</cosponsor>, <cosponsor name-id="G000576">Mr. Grothman</cosponsor>, <cosponsor name-id="J000304">Mr. Jackson of Texas</cosponsor>, and <cosponsor name-id="F000472">Mr. Scott Franklin of Florida</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title III of the Public Health Service Act to reauthorize the program of payments to children’s hospitals that operate graduate medical education programs, and for other purposes.</official-title></form><legis-body id="HA964E77EF5AC41CEB9731D8E7DDBAEAB" style="OLC"><section id="H6A83FC71FAF94D56A8A82689C8CF1C78" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Children’s Hospital GME Support Reauthorization Act of 2025</short-title></quote>.</text></section><section id="H7A96C709F190458CB7EBD6F31242E1A6"><enum>2.</enum><header>Program of payments to children's hospitals that operate graduate medical education programs</header><text display-inline="no-display-inline">Section 340E of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/256e">42 U.S.C. 256e</external-xref>) is amended—</text><paragraph id="H25783FDC0CB849DDB029F319AC9B7280"><enum>(1)</enum><text>in subsection (a), by striking <quote>2023</quote> and inserting <quote>2030</quote>;</text></paragraph><paragraph commented="no" id="H29D14C2AE5634D58BC8DD15C88FE3AF8"><enum>(2)</enum><text>in subsection (b)(3)(D), by inserting <quote>and the end of fiscal year 2030,</quote> after <quote>fiscal year 2022,</quote>;</text></paragraph><paragraph id="H08C99EDCBF56436EB195EBDE7999F628"><enum>(3)</enum><text>in subsection (e), by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="H88F174E86F734AB999473D7FC6AF2011" display-inline="no-display-inline"><paragraph id="HBD17950CBB2246CD876812A8C73E43DF"><enum>(4)</enum><header>Prohibition on payments to hospitals furnishing specified procedures and drugs to minors</header><subparagraph id="H43BDB6FE93204ED7A353C5167BF1F988"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Notwithstanding any other provision of this section, no payment may be made under this section to a children’s hospital for a fiscal year (beginning with fiscal year 2026) if, at any point during the preceding fiscal year, such hospital furnished specified procedures and drugs (as defined in subsection (g)) to an individual under 18 years of age.</text></subparagraph><subparagraph id="H98F28247153F42B0A09B38BFACA1E28E"><enum>(B)</enum><header>Special rule for fiscal year 2026</header><text>In applying subparagraph (A) with respect to payments described in such subparagraph for fiscal year 2026—</text><clause id="HA088E4035B0D4713BBA7ACE9540F61B9"><enum>(i)</enum><text>the reference to <quote>for a fiscal year</quote> shall be treated as a reference to <quote>for any portion of fiscal year 2026 occurring after December 31, 2025</quote>; and </text></clause><clause id="HFDDE265BBABB4809A71E478F85317249"><enum>(ii)</enum><text>the reference to <quote>the preceding fiscal year</quote> shall be treated as a reference to <quote>the period beginning on September 1, 2025, and ending on December 31, 2025</quote>.</text></clause></subparagraph><subparagraph id="HE5F901B7707F41109EAC49DDC1934185"><enum>(C)</enum><header>Rule of construction</header><text display-inline="yes-display-inline">Nothing in this paragraph shall be construed as prohibiting payments for a fiscal year (or, in the case of payments for fiscal year 2026, during the portion of such fiscal year described in subparagraph (B)(i)) to a hospital that, during the preceding fiscal year (or, in the case of payments for fiscal year 2026, during the period described in subparagraph (B)(ii)), furnished mental or behavioral health services to individuals under 18 years of age for the treatment of gender dysphoria not consisting of specified procedures and drugs.</text></subparagraph></paragraph><after-quoted-block>;</after-quoted-block></quoted-block></paragraph><paragraph id="H54FD41DBCC264903902ABAB8397189ED"><enum>(4)</enum><text>in subsection (f)—</text><subparagraph id="H590B0A09034F41D3909E5C7945E2C4A2"><enum>(A)</enum><text>in paragraph (1)(A)—</text><clause id="HE5D69E8085CC4A45B04A97F42BD9F52D"><enum>(i)</enum><text>in clause (v), by striking <quote>and</quote> at the end;</text></clause><clause id="H93B167CFAFDD42A082F4480EA4982E0B"><enum>(ii)</enum><text>in clause (vi), by striking the period at the end and inserting <quote>; and</quote>; and</text></clause><clause id="HE1CD3E8E483B422EBC8C97A78569F2D5"><enum>(iii)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" id="H55B49D6B80B3480084472BDB33B1DEC3" display-inline="no-display-inline"><clause id="H4F82795AA9BB4CD89F4A0AE4D9DB990A"><enum>(vii)</enum><text display-inline="yes-display-inline">for each of fiscal years 2026 through 2030, $124,000,000.</text></clause><after-quoted-block>; and</after-quoted-block></quoted-block></clause></subparagraph><subparagraph id="HBD0B7358C8C5416B90B7FE5E0D7801A5"><enum>(B)</enum><text>in paragraph (2)—</text><clause id="H0261ABC391BF44EE9C98CD90E5EEB1EE"><enum>(i)</enum><text>in subparagraph (E), by striking <quote>and</quote> at the end;</text></clause><clause id="HB9EB502D1E1B478AA6E896885B2F8320"><enum>(ii)</enum><text>in subparagraph (F), by striking the period at the end and inserting <quote>; and</quote>; and</text></clause><clause id="HBC29319E3D934AEE990524F4DFB0C5F8"><enum>(iii)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" id="H4BEB7C1DADA4442B82C3D1AAD0ACC331" display-inline="no-display-inline"><subparagraph id="HC4B5D2ED95F64661966951AEFE16FE97"><enum>(G)</enum><text display-inline="yes-display-inline">for each of fiscal years 2026 through 2030, $261,000,000</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></clause></subparagraph></paragraph><paragraph id="H04646A8380B54B4B9B1CCC8ED7F968EA"><enum>(5)</enum><text>in subsection (g), by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="H996E1CB00E96412FAB40C9A41BC9F133" display-inline="no-display-inline"><paragraph id="HA9AACCE85A1044DAB74E30BFC74B8A03"><enum>(4)</enum><header>Specified procedures and drugs</header><subparagraph id="H5D008F8076024A919BFD839D07DB92AE"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Except as provided in subparagraph (B), the term <term>specified procedures and drugs</term> means, with respect to an individual, any of the following:</text><clause id="HE8569BA7A8354DBA90131A8B1FE53D48"><enum>(i)</enum><text display-inline="yes-display-inline">Performing any surgery for the purpose of changing the body of such individual to no longer correspond to the individual’s sex, including—</text><subclause id="H251A899A51984BA9ACD9D4E5FB6A9FF5"><enum>(I)</enum><text>castration;</text></subclause><subclause id="H4F13B5D44CE940929F8FDE6EF4A000CC"><enum>(II)</enum><text>orchiectomy;</text></subclause><subclause id="H62FAE23C31D04203A17B739E08FA2D73"><enum>(III)</enum><text>scrotoplasty;</text></subclause><subclause id="H38BFB2DC190847AD99BBE3032EB18855"><enum>(IV)</enum><text>vasectomy;</text></subclause><subclause id="H1702683405B74CD0AF14AEC56D02B28D"><enum>(V)</enum><text>hysterectomy;</text></subclause><subclause id="H77D076B8773D4A62892D4331008A6CCC"><enum>(VI)</enum><text>oophorectomy;</text></subclause><subclause id="HAF7EBBFDBA244B928CBB6116B2A486E2"><enum>(VII)</enum><text>ovariectomy;</text></subclause><subclause id="HF7AC393D87E54FCBAC54862BD8F4BA74"><enum>(VIII)</enum><text>metoidioplasty; </text></subclause><subclause id="HF2F8924FE2C549C2B88CE388E7E50068"><enum>(IX)</enum><text>penectomy; </text></subclause><subclause id="HA2B0744B5C3C4BCB85B9EDB5BBCDDFD3"><enum>(X)</enum><text>phalloplasty; </text></subclause><subclause id="HA1C398DD7CFA42E8944A39D21A0A4DDC"><enum>(XI)</enum><text>vaginoplasty; </text></subclause><subclause id="H14EB31701AD047C6B49F4203DEB06136"><enum>(XII)</enum><text>vaginectomy; </text></subclause><subclause id="H8A89E6E1598240308147815344E741CB"><enum>(XIII)</enum><text>vulvoplasty; </text></subclause><subclause id="HDF2CB370D6FD44D79650FB73EC987701"><enum>(XIV)</enum><text>reduction thyrochondroplasty;</text></subclause><subclause id="H5AC07EF2F9FD4E879E770EC792D0D175"><enum>(XV)</enum><text display-inline="yes-display-inline">chondrolaryngoplasty, or any plastic surgery that feminizes or masculinizes the facial features;</text></subclause><subclause id="H240D6DD42AF541DF86C8A6C583C15876"><enum>(XVI)</enum><text display-inline="yes-display-inline">mastectomy, or any placement of chest implants to create feminine breasts; and</text></subclause><subclause id="H47EDEDDB6C3049229FC1848F1B7FA184"><enum>(XVII)</enum><text display-inline="yes-display-inline">Any placement of fat or artificial implants in the gluteal region. </text></subclause></clause><clause id="H8AFFB36F907942DE950A53AB1A5B82E6"><enum>(ii)</enum><text display-inline="yes-display-inline">Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications for the purposes described in clause (i), including gonadotrophin releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty, and estrogen, testosterone, progesterone, or other androgens to an individual in an amount greater than would normally be produced endogenously in a healthy individual of that individual’s age and sex.</text></clause></subparagraph><subparagraph id="HF142ECC5459E453F839D225C1009EC32"><enum>(B)</enum><header>Exception</header><text display-inline="yes-display-inline">Subparagraph (A) shall not apply to the provision by a physician or health care provider, with the consent of the child’s parent or legal guardian, of—</text><clause id="H367E1A0057F74B1581D550D1AC12AE6F"><enum>(i)</enum><text>puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for a minor experiencing precocious puberty;</text></clause><clause id="HBEB07D26E255413CBD4D0F174290B7A3"><enum>(ii)</enum><text>appropriate and medically necessary procedures or treatments to correct for—</text><subclause id="HD8934A0B32DC4E7E955895AD37DEC848"><enum>(I)</enum><text>a medically verifiable genetic disorder of sex development, including—</text><item id="HA77F922611734F799CE71F0EAAE31125"><enum>(aa)</enum><text>46,XX chromosomes with virilization;</text></item><item id="HC8D08D8E21134EFF96F89B294EEC3A95"><enum>(bb)</enum><text>46,XY chromosomes with undervirilization; and</text></item><item id="HEC784A2297CB4F39938DB670FC4EA7C2"><enum>(cc)</enum><text>both ovarian and testicular tissue; or</text></item></subclause><subclause id="HF94A265C68F24C0BA9BBF3CCC9DA82A9"><enum>(II)</enum><text>sex chromosome structure, sex steroid hormone production, or sex hormone action, if determined to be abnormal by a physician through genetic or biochemical testing; </text></subclause></clause><clause id="H70E1057EA77A418C8666644E60D33B21"><enum>(iii)</enum><text>infection, disease, injury, or disorder caused or exacerbated by previous medical procedures as defined in subsection (g)(4)(A); or </text></clause><clause id="HF99ABE316FA945B48712679BE32A5552"><enum>(iv)</enum><text>a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including if the procedure or drug is for the purpose described in subsection (g)(4)(A)(i).</text></clause></subparagraph><subparagraph id="H0367A21C35B94A1C909F0363973412C7" display-inline="no-display-inline"><enum>(C)</enum><header>Sex</header><text display-inline="yes-display-inline">For purposes of subparagraph (A), the term <term>sex</term> means the indication of male or female sex by reproductive potential or capacity, sex chromosomes, naturally occurring sex hormones, gonads, or internal or external genitalia present at birth.</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section></legis-body></bill> 

